1. Home
  2. RVMD vs DOX Comparison

RVMD vs DOX Comparison

Compare RVMD & DOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • DOX
  • Stock Information
  • Founded
  • RVMD 2014
  • DOX 1982
  • Country
  • RVMD United States
  • DOX United States
  • Employees
  • RVMD N/A
  • DOX N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • DOX EDP Services
  • Sector
  • RVMD Health Care
  • DOX Technology
  • Exchange
  • RVMD Nasdaq
  • DOX Nasdaq
  • Market Cap
  • RVMD 8.7B
  • DOX 10.2B
  • IPO Year
  • RVMD 2020
  • DOX 1998
  • Fundamental
  • Price
  • RVMD $40.16
  • DOX $85.70
  • Analyst Decision
  • RVMD Strong Buy
  • DOX Strong Buy
  • Analyst Count
  • RVMD 13
  • DOX 5
  • Target Price
  • RVMD $65.15
  • DOX $101.20
  • AVG Volume (30 Days)
  • RVMD 1.3M
  • DOX 595.7K
  • Earning Date
  • RVMD 02-24-2025
  • DOX 02-04-2025
  • Dividend Yield
  • RVMD N/A
  • DOX 2.24%
  • EPS Growth
  • RVMD N/A
  • DOX N/A
  • EPS
  • RVMD N/A
  • DOX 4.25
  • Revenue
  • RVMD $742,000.00
  • DOX $5,004,989,000.00
  • Revenue This Year
  • RVMD N/A
  • DOX N/A
  • Revenue Next Year
  • RVMD $1,855.56
  • DOX $4.75
  • P/E Ratio
  • RVMD N/A
  • DOX $19.99
  • Revenue Growth
  • RVMD N/A
  • DOX 2.40
  • 52 Week Low
  • RVMD $26.56
  • DOX $74.41
  • 52 Week High
  • RVMD $62.40
  • DOX $94.04
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 31.31
  • DOX 52.84
  • Support Level
  • RVMD $39.48
  • DOX $81.75
  • Resistance Level
  • RVMD $42.97
  • DOX $85.50
  • Average True Range (ATR)
  • RVMD 1.48
  • DOX 1.26
  • MACD
  • RVMD -0.07
  • DOX 0.18
  • Stochastic Oscillator
  • RVMD 13.59
  • DOX 86.43

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

About DOX Amdocs Limited

Amdocs Ltd is a provider of software and services to communications, cable and satellite, entertainment, and media industry service providers. The Company and its subsidiaries operate in one operating segment, providing software products and services for the communications, entertainment and media industry service being designed, develop, market, support, implement, and operate its open and modular cloud offering. The company offers business support systems, operational support systems, and managed services. Geographically, it derives a majority of revenue from North America and also has a presence in Europe and the Rest of the world.

Share on Social Networks: